{"id":"https://genegraph.clinicalgenome.org/r/c239641f-9ae9-4465-ac45-34924d3a74bev1.0","type":"EvidenceStrengthAssertion","dc:description":"RNF168 was first reported in relation to autosomal recessive RIDDLE syndrome in 2009 (Stewart et al., PMID: 19203578). RIDDLE syndrome is named for its clinical features which include Radiosensitivity, ImmunoDeficiency, Dysmorphic features, and LEarning difficulties. Four variants (nonsense and frameshift) that have been reported in 3 probands in 3 publications are included in this curation (PMIDs: 19203578, 21394101, 29255463). Information regarding the phenotype of heterozygous carriers is limited; however, one parent of a proband was noted to have B cell chronic lymphocytic leukemia (PMID: 19203578). The mechanism of pathogenicity is loss of function.\n\nThis gene-disease association is supported by biochemical studies, functional and rescue assays, and an animal model (PMIDs: 19203578, 17940005, 29255463, 21394101, 21552324). RNF168 is critical for double stranded break repair (PMID: 19203578), and RIDDLE syndrome patient cells show defects in 53BP1-mediated DNA damage signaling (PMID: 17940005, 29255463). These defects are rescued by wild type RNF168 (PMID: 19203578, 21394101). RNF168 knockout mice have radiosensitivity and immunodeficiency consistent with RIDDLE syndrome (PMID: 21552324).\n\nIn summary, RNF168 is definitively associated with autosomal recessive RIDDLE syndrome. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the ClinGen SCID/CID GCEP on the meeting date July 21, 2022 (SOP Version 9).\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/c239641f-9ae9-4465-ac45-34924d3a74be","GCISnapshot":"https://genegraph.clinicalgenome.org/r/2eab353f-d7ed-4f22-883e-0b62c7bc4f9b","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/2eab353f-d7ed-4f22-883e-0b62c7bc4f9b_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10081","date":"2022-08-08T18:05:58.617Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/2eab353f-d7ed-4f22-883e-0b62c7bc4f9b_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10081","date":"2022-08-08T17:00:00.000Z","role":"Approver"}],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2eab353f-d7ed-4f22-883e-0b62c7bc4f9b_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2eab353f-d7ed-4f22-883e-0b62c7bc4f9b_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bdf7673d-0355-4474-8a60-ec405b6f6ab5","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/94d06349-11de-43a8-b38d-c5fb02bde701","type":"Finding","dc:description":"Both patients with RIDDLE syndrome and RNF168 knock out mice show immunodeficiency, specifically impaired class switch recombination, and increased cellular sensitivity to radiation. Neither have defects in T- or B- cell numbers but have significantly lower serum IgG concentration (Figure 5A). Class switch recombination of various IgG isotypes in knockout mice is also impaired (Figure 5B, 5C, 5D). Knockout lymphocytes demonstrate a significant increase in the sensitivity to infrared radiation and ultra violet treatment (Figure 1A).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21552324","rdfs:label":"Mouse model","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/5058e449-5a57-438c-bbf0-a8c574e20d4d","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/99d25fdb-604d-490f-8c3f-d0e0896ebe3e","type":"Finding","dc:description":"Wild-type HA-RNF168 restores radio resistance to the 15-9BI fibroblasts (Figure 2E).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19203578","rdfs:label":"Stewart Patient Cell Rescue","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityPatientCellRescueCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/73f94d64-dd6e-4bd9-9782-367e986d80d6","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4fd36bae-651a-4fde-b04d-b498b3ad66ab","type":"Finding","dc:description":"This rescue robustly restored both 53BP1 and BRCA1 retention in IR-induced nuclear foci (Figure 4b).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21394101","rdfs:label":"Devgan Patient Cell Rescue","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityPatientCellRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":4},{"id":"https://genegraph.clinicalgenome.org/r/2eab353f-d7ed-4f22-883e-0b62c7bc4f9b_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8710d839-7eb9-49df-82f3-d8dad1f74a94","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8d5c769c-18bf-4a37-9881-6b3f116a11b4","type":"FunctionalAlteration","dc:description":"Patient cells show defects in 53BP1-mediated DNA damage signaling. They exhibit a hypersensitivity to ionizing radiation (Figure 1), fail to form 53BP1 ionizing radiation induced foci after gamma irradiation (Figure 3), and have cell cycle checkpoint abnormalities, failing to recover at 8h and 24h post radiation (Figure 4).","dc:source":"https://pubmed.ncbi.nlm.nih.gov/17940005","rdfs:label":"Stewart Functional Alteration"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/f8457b89-edf4-4f10-be3c-775ea7a238fc","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/6e1917bb-37ee-4a69-8e9e-5c9294ab1462","type":"FunctionalAlteration","dc:description":"The formation and disappearance of 53BP1 repair foci were monitored over time in both lymphoblastoid cells and fibroblasts from both patients. The fibroblasts from both patients failed to form any detectable 53BP1 foci (Figure 3; Table 1). Similarly, we could not detect any 53BP1 foci after irradiation in lymphoblastoid cells from both patients.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29255463","rdfs:label":"Pietrucha functional alteration"}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/2eab353f-d7ed-4f22-883e-0b62c7bc4f9b_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/674b71ee-568c-45c9-a5b1-c8074af3011e","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1ee4a294-be0f-48c9-a2f2-e537c2f57e7c","type":"Finding","dc:description":"Individuals with RIDDLE syndrome due to RNF168 exhibit increased cellular radiosensitivity. This is a key feature of the syndrome present in all patients reported in the literature to date.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19203578","rdfs:label":"Stewart biochemical","demonstrates":{"id":"cg:BiochemicalFunctionB"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":6},{"id":"https://genegraph.clinicalgenome.org/r/2eab353f-d7ed-4f22-883e-0b62c7bc4f9b_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/2eab353f-d7ed-4f22-883e-0b62c7bc4f9b_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9bd6748d-4481-4f71-a527-bac55cd8ccce_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29255463","rdfs:label":"Pietrucha siblings","family":{"id":"https://genegraph.clinicalgenome.org/r/9bd6748d-4481-4f71-a527-bac55cd8ccce","type":"Family","rdfs:label":"Pietrucha siblings","member":{"id":"https://genegraph.clinicalgenome.org/r/bb97a489-466b-4163-86fe-f9eac6791a8e","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29255463","rdfs:label":"HA592","ageType":"AgeAtReport","ageUnit":"Years","ageValue":21,"allele":{"id":"https://genegraph.clinicalgenome.org/r/876d9f40-1658-44dc-924e-932843218564","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152617.4(RNF168):c.295del (p.Glu99LysfsTer18)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA2573130181"}},"firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0010997","obo:HP_0002275","obo:HP_0004313","obo:HP_0006254","obo:HP_0001009"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/4bc8245c-3d67-4415-88b9-6ebf9ea60c71_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29255463","allele":{"id":"https://genegraph.clinicalgenome.org/r/876d9f40-1658-44dc-924e-932843218564"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}}},"phenotypePositiveAllelePositive":2,"proband":{"id":"https://genegraph.clinicalgenome.org/r/bb97a489-466b-4163-86fe-f9eac6791a8e"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/b05d90ef-23ad-4b31-b694-e7d9fff6949f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1580fd72-3753-483e-a8ce-9e2520a34686","type":"EvidenceLine","dc:description":"3 alleles in gnomad; NMD+","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1580fd72-3753-483e-a8ce-9e2520a34686_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21394101","allele":{"id":"https://genegraph.clinicalgenome.org/r/dbe2bdaf-892b-4bbe-a561-f755d707b05f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152617.4(RNF168):c.391C>T (p.Arg131Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA215012"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/b05d90ef-23ad-4b31-b694-e7d9fff6949f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/21394101","rdfs:label":"RS66","ageUnit":"Years","ageValue":16,"allele":{"id":"https://genegraph.clinicalgenome.org/r/dbe2bdaf-892b-4bbe-a561-f755d707b05f"},"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0001251","obo:HP_0002136","obo:HP_0002721","obo:HP_0000252","obo:HP_0001009","obo:HP_0004322","obo:HP_0010997","obo:HP_0002720","obo:HP_0002878","obo:HP_0006254","obo:HP_0000958"],"previousTesting":true,"previousTestingDescription":"ATM was tested","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/1580fd72-3753-483e-a8ce-9e2520a34686_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/bb97a489-466b-4163-86fe-f9eac6791a8e_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4bc8245c-3d67-4415-88b9-6ebf9ea60c71","type":"EvidenceLine","dc:description":"absent in gnomad; NMD+","calculatedScore":3.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4bc8245c-3d67-4415-88b9-6ebf9ea60c71_variant_evidence_item"}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/bb97a489-466b-4163-86fe-f9eac6791a8e"}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3.0},{"id":"https://genegraph.clinicalgenome.org/r/f4a4ca24-b59c-4720-a483-e5166939adab_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e0537e09-facd-45aa-a899-2f76a1a4ad6f","type":"EvidenceLine","dc:description":"c.397dup (p.Ala133fs) is absent in gAD and is expected to undergo NMD.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e0537e09-facd-45aa-a899-2f76a1a4ad6f_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19203578","allele":{"id":"https://genegraph.clinicalgenome.org/r/6ac1109c-3a90-466d-a1bb-d196125802b4","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152617.4(RNF168):c.397dup (p.Ala133fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/487"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/26888644-f278-47f7-b53e-8ade99880c26","type":"EvidenceLine","dc:description":"c.1323_1326del (p.Gln442fs) is absent in gAD but is not anticipated to undergo NMD as it occurs in the last exon.","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/26888644-f278-47f7-b53e-8ade99880c26_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19203578","allele":{"id":"https://genegraph.clinicalgenome.org/r/79582766-2d8f-4a45-8cab-f6a027b02780","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_152617.4(RNF168):c.1323_1326del (p.Gln442fs)","https://terms.ga4gh.org/CanonicalReference":{"id":"https://www.ncbi.nlm.nih.gov/clinvar/variation/488"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/f4a4ca24-b59c-4720-a483-e5166939adab","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19203578","rdfs:label":"15-9BI","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":1,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/6ac1109c-3a90-466d-a1bb-d196125802b4"},{"id":"https://genegraph.clinicalgenome.org/r/79582766-2d8f-4a45-8cab-f6a027b02780"}],"firstTestingMethod":"Sanger sequencing","phenotypes":["obo:HP_0001328","obo:HP_0002275","obo:HP_0001999","obo:HP_0004313","obo:HP_0004322","obo:HP_0010997","obo:HP_0002721"],"sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/e0537e09-facd-45aa-a899-2f76a1a4ad6f_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/26888644-f278-47f7-b53e-8ade99880c26_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":8.5}],"evidenceStrength":"Definitive","sequence":4921,"specifiedBy":"GeneValidityCriteria9","strengthScore":14.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/3Y4UL8TUhW8","type":"GeneValidityProposition","disease":"obo:MONDO_0012764","gene":"hgnc:26661","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_2eab353f-d7ed-4f22-883e-0b62c7bc4f9b-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}